Latest Articles

Publication Date
All News Scientific
Neoadjuvant Nivolumab Appears Effective for Resectable, dMMR Endometrial Cancer - Oncology Nurse Advisor

Neoadjuvant Nivolumab Appears Effective for Resectable, dMMR Endometrial Cancer Oncology Nurse Advisor

Published: April 8, 2025, 4 a.m.
Read Full Article
Sexual dysfunction and quality of life in cervical and endometrial cancer patients before and after low-dose-rate brachytherapy: a cohort study - Frontiers

Sexual dysfunction and quality of life in cervical and endometrial cancer patients before and after low-dose-rate brachytherapy: a cohort study Frontiers

Published: April 4, 2025, 8:35 p.m.
Read Full Article
Endometrial Cancer Treatment Market 2034: Clinical Trials, - openPR.com

Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com

Published: April 4, 2025, 4:30 a.m.
Read Full Article
SGO 2025: Impact of Precision Medicine in Endometrial Cancer - Medscape

SGO 2025: Impact of Precision Medicine in Endometrial Cancer Medscape

Published: April 3, 2025, 5:21 p.m.
Read Full Article
Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer - Oncology Nurse Advisor

Metformin Plus Letrozole & Abemaciclib Appears Safe, Effective in Endometrial Cancer Oncology Nurse Advisor

Published: April 3, 2025, 4 a.m.
Read Full Article
'Ovariostasis' as the main preventive and therapeutic strategy for gynecological pathologies in women of reproductive age.

Ovariostasis is a reversible and temporary suspension of the cyclic ovarian activity, characterized by anovulation and hypogonadotropinemia (low serum concentrations of FSH and LH), which can be observed in case …

Published: April 3, 2025, midnight
Read Full Article
gynecological pathology ovarian activity ovariostasis ovulation suppression prevention treatment
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position - TipRanks

Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position TipRanks

Published: April 1, 2025, 6:54 p.m.
Read Full Article
Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis - ScienceDirect.com

Excess heme orchestrates progesterone resistance in uterine endometrial cancer through macrophage polarization and the IL-33/PAX8/PGR axis ScienceDirect.com

Published: April 1, 2025, 2:47 p.m.
Read Full Article
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR - Nature

Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR Nature

Published: April 1, 2025, 1:15 p.m.
Read Full Article
Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer - OncLive

Dr Lee on Responses With Nivolumab in Resectable dMMR Endometrial Cancer OncLive

Published: March 31, 2025, 10:21 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!